Ashurst and Perkins Coie have advised the underwriters on RIGOL Technologies Co., Ltd’s global offering and listing of H shares on the Main Board of The...
RIGOL Technologies Secures HK$1.14 Billion in Global Hong Kong IPO
HXPharma Completes HK$993.6 Million Hong Kong IPO
Ashurst has advised Fujian Haixi Pharmaceutical Co., Ltd. (HXPharma). Fujian Haixi Pharmaceutical Co., Ltd. (HXPharma) has successfully completed its global offering of shares and listing on...


























